news.abbvie.com
Open in
urlscan Pro
34.199.121.2
Public Scan
Submitted URL: http://bonti.com/
Effective URL: https://news.abbvie.com/index.cfm
Submission: On January 01 via api from US — Scanned from DE
Effective URL: https://news.abbvie.com/index.cfm
Submission: On January 01 via api from US — Scanned from DE
Form analysis 3 forms found in the DOM
Name: fm_search_header — POST /search_results.cfm
<form name="fm_search_header" id="fm_search_header" action="/search_results.cfm" method="post" role="form">
<input type="hidden" name="content_type_id" value="0">
<input type="hidden" name="newsearch" value="">
<div class="input-group input-group-sm">
<label for="keywords" class="hidden"> Search</label>
<input type="text" id="keywords" name="keywords" value="" placeholder=" Search" class="form-control" title=" Search">
<span class="search-icon-custom">
<a href="javascript:document.fm_search_header.submit();" title=" Search"></a>
</span>
</div>
</form>Name: hp-filter — POST /index.cfm#all-news
<form name="hp-filter" method="POST" action="/index.cfm#all-news">
<h3>Filter by categories</h3>
<label for="filter_news_type" class="sr-only">All News Type</label>
<select id="filter_news_type" class="select-brand-style select-hp" name="news_type" tabindex="0">
<option value="0">All news types</option>
<option value="64">Corporate News</option>
<option value="65">R&D News</option>
<option value="66">Product News</option>
<option value="67">Responsibility News</option>
<option value="4">Media Statements</option>
<option value="11">News Briefs</option>
</select>
<label for="filter_ta" class="sr-only">All therapeutic areas</label>
<select id="filter_ta" class="select-brand-style select-hp" name="ta" tabindex="0">
<option value="" selected="">All therapeutic areas</option>
<option value="68">Immunology</option>
<option value="70">Women’s Health</option>
<option value="72">Virology</option>
<option value="73">General Medicine</option>
<option value="69">Oncology</option>
<option value="71">Neuroscience</option>
<option value="76">Allergan Aesthetics</option>
<option value="77">Eye Care</option>
</select>
<label for="filter_archive_year" class="sr-only">All Years</label>
<select id="filter_archive_year" name="archiveYear" class="select-brand-style" style="">
<option value="all">All years</option>
<option value="2023">2023</option>
<option value="2022">2022</option>
<option value="2021">2021</option>
<option value="2020">2020</option>
<option value="2019">2019</option>
<option value="2018">2018</option>
<option value="2017">2017</option>
<option value="2016">2016</option>
<option value="2015">2015</option>
<option value="2014">2014</option>
<option value="2013">2013</option>
</select>
<br><br><br>
<input type="submit" class="cta-btn btn-dark" value="Search" style="border: 2px solid #000;">
</form>Name: fm_login_popup — POST https://news.abbvie.com/login.cfm
<form name="fm_login_popup" id="fm_login_popup" action="https://news.abbvie.com/login.cfm" method="post" role="form">
<input type="hidden" name="new_path_info" value="/index.cfm">
<div class="form-group">
<label for="popup_login_id"> Login:</label>
<input type="text" name="login_id" id="popup_login_id" size="25" class="form-control">
</div>
<div class="form-group">
<label for="popup_site_pass"> Password:</label>
<input type="password" name="site_pass" id="popup_site_pass" size="25" class="form-control">
</div>
<div class="form-group">
<button type="submit" name="submit" class="btn btn-primary btn-sm" title=" Login" tabindex="0"> Login</button>
</div>
</form>Text Content
* Investors
* News Center
* Patient Assistance
News Center
Menu
* News
* Press Kits
* Media Resources
* Fact Sheets
* Images
* Video
* Media Contacts
* Investors
* News Center
* Patient Assistance
Search
LATEST NEWS
December 16, 2022 U.S. FDA Approves VRAYLAR® (cariprazine) as an Adjunctive
Treatment for Major Depressive Disorder
December 16, 2022 AbbVie Submits Supplemental New Drug Application to U.S. FDA
to Support New Indication of LINZESS® (linaclotide) for Functional Constipation
in Children and Adolescents 6 to 17 Years of Age
December 12, 2022 AbbVie Named to Dow Jones Sustainability World Index for 10th
Straight Year
ABBVIE ON TWITTER
Looking for more news from AbbVie?
Follow us on social media.
QUICK LINKS
FACT SHEET
See a high-level overview about our business.
IMAGE LIBRARY
Our media library provides you with our official AbbVie media including our
logo, building and leaders.
SUBSCRIBE
Stay up to date on recent news, articles, and more.
--------------------------------------------------------------------------------
FILTER BY CATEGORIES
All News Type All news types Corporate News R&D News Product News Responsibility
News Media Statements News Briefs All therapeutic areas All therapeutic
areasImmunologyWomen’s HealthVirologyGeneral
MedicineOncologyNeuroscienceAllergan AestheticsEye Care All Years All years 2023
2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
ALL NEWS
December 11, 2022
AbbVie Presents Data at the 64th American Society of Hematology (ASH) Annual
Meeting Evaluating Epcoritamab (DuoBody®-CD3xCD20) Across B-Cell Lymphomas
December 10, 2022
AbbVie Presents Data at the 64th American Society of Hematology (ASH) Annual
Meeting for Investigational Navitoclax in Combination With Ruxolitinib for JAK
Inhibitor-Naïve Myelofibrosis Patients
December 10, 2022
AbbVie Presents Data at the 64th American Society of Hematology (ASH) Annual
Meeting Adds to Robust IMBRUVICA® (ibrutinib) Science
December 06, 2022
AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further
Expand Immunology Pipeline
December 06, 2022
AbbVie to Showcase Migraine Portfolio and Pipeline During the 16th European
Headache Federation Congress
November 23, 2022
AbbVie to Present at the Evercore ISI HealthCONx Conference
November 23, 2022
AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the
Treatment of Moderate to Severe Active Crohn's Disease
November 22, 2022
AbbVie Highlights Blood Cancer Data From Its Growing Oncology Pipeline at the
64th ASH Annual Meeting
November 22, 2022
AbbVie to Present at the Piper Sandler Healthcare Conference
November 22, 2022
Statement on Allergan Nationwide Settlement to Resolve Opioid-Related Claims
* «
* 1
* 2
* 3
* 4
* 5
* …
* 99
* 100
* »
* << Back
* Next >>
--------------------------------------------------------------------------------
MORE INFORMATION
OUR HISTORY
Explore where we've been and how we continue to go beyond medicine to make a
remarkable impact. Learn more
SOCIETAL IMPACT
Our commitment to science is a commitment to better our society. Read our 2021
ESG report
RATINGS AND RECOGNITION
We've been honored to receive some of the most prestigious ratings and
recognnitions in the industry. Learn more
ANNUAL REPORT
See our latest 2021 Annual Report on Form 10-K. Learn more
The information in the press releases on these pages was factually accurate on
the date of publication. These press releases remain on AbbVie's website for
historical purposes only. AbbVie assumes no duty to update the information to
reflect subsequent developments. Readers should not rely upon the information in
these pages as current or accurate after their publication dates.
For more information
Contact us »
Subscribe for email alerts
Sign up
Subscription management
AbbVie social media
twitter facebook linkedin Instagram youtube
We also welcome the opportunity to hear from you in these social channels, but
remember we work in a highly-regulated industry with unique legal
considerations. Before engaging, please read and adhere to our established
community guidelines for each channel.
View our social media channel guidelines »
AbbVie.com | Site map | Privacy policy | Terms of use | Cookie Settings
Copyright © 2023 AbbVie Inc. North Chicago, Illinois, U.S.A.
Unless otherwise specified, all product names appearing in this Internet site
are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or
affiliates. No use of any AbbVie trademark, trade name, or trade dress in this
site may be made without the prior written authorization of AbbVie Inc., except
to identify the product or services of the company.
You must be logged in to view this item.
Login:
Password:
Login
This area is reserved for members of the news media. If you qualify, please
update your user profile and check the box marked "Check here to register as an
accredited member of the news media". Please include any notes in the
"Supporting information for media credentials" box. We will notify you of your
status via e-mail in one business day.
YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE
Notice
The "Yes" link below will take you out of the AbbVie family of websites.
Links which take you out of the AbbVie worldwide websites are not under the
control of AbbVie, and AbbVie is not responsible for the contents of any such
site or any further links from such site. AbbVie is providing these links to you
only as a convenience and the inclusion of any link does not imply endorsement
of the linked site by AbbVie.
The Internet site that you have requested may not be optimized to your screen
size.
Do you wish to leave this site?
This site uses online tracking technologies such as cookies to personalize
content, save your preferences, provide social media features, enable
personalized advertising and track the site’s performance as described in our
Privacy Notice. Please click on Cookies Settings below to manage your
preferences.
Cookie Settings Accept All Cookies
PRIVACY PREFERENCE CENTER
When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience.
You can choose not to allow some types of cookies. Click on the different
category headings to find out more and change our default settings. However,
blocking some types of cookies may impact your experience of the site and the
services we are able to offer.
More information
Allow All
MANAGE COOKIE SETTINGS
REQUIRED COOKIES
Always Active
These cookies are necessary for the website to function and cannot be switched
off in our systems. They may be set by us or by third party providers whose
services we have added to our pages. They are usually only set in response to
actions made by you which amount to a request for services, such as setting your
privacy preferences, logging in or filling in forms. You can set your browser to
block or alert you about these cookies, but some parts of the site will not
work.
View Vendor Details
FUNCTIONAL COOKIES
Functional Cookies
These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They may be set by us or by third party
providers whose services we have added to our pages. They help us to know which
pages are the most and least popular and see how visitors move around the site.
All information these cookies collect is aggregated and therefore anonymous. If
you do not allow these cookies we will not be able to monitor our site’s
performance or learn how to make it better.
View Vendor Details
ANONYMOUS PERFORMANCE COOKIES
Anonymous Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They may be set by us or by third party
providers whose services we have added to our pages. They help us to know which
pages are the most and least popular and see how visitors move around the site.
All information these cookies collect is aggregated and therefore anonymous. If
you do not allow these cookies we will not be able to monitor our site’s
performance or learn how to make it better.
View Vendor Details
ADVERTISING COOKIES
Advertising Cookies
These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.
View Vendor Details
Back Button
PERFORMANCE COOKIES
Search Icon
Filter Icon
Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label
*
View Cookies
* Name
cookie name
Confirm My Choices